Key statistics
As of last trade RESMED INC DRN ED (R1MD34:SAO) traded at 357.12, -3.14% below its 52-week high of 368.70, set on Oct 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 355.68 |
---|---|
High | 360.00 |
Low | 355.68 |
Bid | 347.76 |
Offer | 357.84 |
Previous close | 357.12 |
Average volume | 57.40 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 1.91 BRL |
---|---|
Annual div yield (ADY) | 0.53% |
Div ex-date | Nov 06 2024 |
Div pay-date | Dec 18 2024 |
Data delayed at least 15 minutes, as of Nov 13 2024 13:20 GMT.
More ▼
- ResMed Announces Participation in the UBS Global Healthcare Conference
- ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
- ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
- ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
- UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
- UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
- ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange
- Vaping Expected to Increase COPD Health and Economic Burden by 2050
- ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
- ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
More ▼